NBY Stock Analysis: Buy, Sell, or Hold?
NBY - NovaBay Pharmaceuticals, Inc.
$1.86
0.01 (0.54%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When NBY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NBY this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NBY is down 60.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NBY is down 60.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NBY is currently trading at $1.86, which is considered oversold relative to its 30-day fair value range of $2.89 to $11.64.
Technical Outlook: Technically, NBY is in a uptrend. Immediate support is located at $1.79, while resistance sits at $18.40.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $0.85. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBY is in a uptrend. Immediate support is located at $1.79, while resistance sits at $18.40.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $0.85. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.89 -
$11.64
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
Protect Your Profits
Holding NBY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 54.1% above Wall St target ($0.85)
- WARNING: Recommendation downgraded due to -60.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.89 -
$11.64
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.79
Resistance Level
$18.40
Current Trend
Uptrend
Fundamental Context
Wall Street Target
$0.85
(-54.1%)
Revenue Growth (YoY)
-78.7%
Profit Margin
31.5%
Last updated: January 31, 2026 10:19 AM ET
Data refreshes hourly during market hours. Next update: 11:19 AM
Data refreshes hourly during market hours. Next update: 11:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBY showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced NBY Option Strategies
Professional options setups generated by AI based on today's NBY price and gamma walls.
